Search For "us food and drug administration"
Moderna to request Emergency use authorisation, its vaccine 100% effective
Updated : 5 years, 3 months ago IST
Washington [US], November 30 (ANI): US biotech company Moderna on Monday announced that it plans to request an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA) after the final results from a lat
Read More
Pfizer, BioNTech to submit to FDA for emergency use authorisation for thei
Updated : 5 years, 3 months ago IST
Washington [US], November 20 (ANI): American drug giant Pfizer and German laboratory BioNTech on Friday said that they will be submitting to the US Food and Drug Administration for emergency use authorisation for their COVID-19 vaccine candidate.
Read More
US allows emergency use of Eli Lilly's COVID-19 antibody treatment
Updated : 5 years, 4 months ago IST
Washington DC [US], November 10 (ANI): The US Food and Drug Administration (FDA) has approved an emergency use authorisation (EUA) for American pharmaceutical company Eli Lilly's experimental COVID-19 antibody treatment called 'bamlanivimab' for non-hospitalised patients with mild-to-moderat
Read More
Credit metrics of leading pharma companies to remain stable: ICRA
Updated : 5 years, 5 months ago IST
New Delhi [India], Sep 26 (ANI): The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic nature of prescription drugs, investment information agency ICRA has said.
Read More
Equity indices trade higher, Eicher Motors top gainer
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], Aug 24 (ANI): Equity benchmark indices traded on a positive note during early hours on Monday led by gains in financial and auto stocks.
Read More
Trump announces emergency authorization of convalescent plasma to treat C
Updated : 5 years, 6 months ago IST
Washington D.C. [US], August 24 (ANI): The US Food and Drug Administration (FDA) has authorised the use of convalescent plasma for the treatment of COVID-19 patients.
Read More
US authorises use of saliva test for COVID-19: FDA
Updated : 5 years, 7 months ago IST
Washington [US], August 16 (ANI/Sputnik): The United States' Food and Drug Administration (FDA) has approved a new COVID-19 testing method based on analysing saliva samples.
Read More
Jubilant launches Remdesivir in India for treatment of COVID-19
Updated : 5 years, 7 months ago IST
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Read More
FDA issues first emergency use authorisation for COVID-19 pool testing
Updated : 5 years, 8 months ago IST
Washington D.C. [USA], July 19 (ANI): The US Food and Drug Administration (FDA) on Saturday (local time) issued an emergency use authorisation (EUA) to Quest Diagnostics that allows pool samples from up to four individuals to test for COVID-19.
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
US FDA revokes emergency authorisation for HCQ championed by President Tru
Updated : 5 years, 9 months ago IST
Washington D.C. [US], June 15 (ANI): The US Food and Drug Administration (FDA) on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine (HCQ) as a treatment for COVID-19, the use of which has been championed by President Donald Trump.
Read More